Treatment of De Novo Renal Transplant Recipients With Calcineurin Inhibitor-free, Belatacept Plus Everolimus-based Immunosuppression.

Peddi, V Ram; Marder, Bradley; Gaite, Luis; Oberholzer, Jose; Goldberg, Ryan; Pearson, Thomas; Yang, Harold; Allamassey, Lisa; Polinsky, Martin; Formica, Richard N

Peddi, V Ram; Marder, Bradley; Gaite, Luis; Oberholzer, Jose; Goldberg, Ryan; Pearson, Thomas; Yang, Harold; Allamassey, Lisa; Polinsky, Martin; Formica, Richard N.

Afiliação

Peddi VR; Department of Transplantation, California Pacific Medical Center, San Francisco, CA.
Marder B; Division of Transplant Research, Colorado Kidney Care, Denver, CO.
Gaite L; Sección Hepatología, Clinica de Nefrología, Santa Fe, Argentina.
Oberholzer J; Division of Transplant Surgery, Department of Surgery, University of Virginia Health System, Charlottesville, VA.
Goldberg R; Renal and Pancreas Transplant Division, Saint Barnabas Medical Center, Livingston, NJ.
Pearson T; Emory Transplant Center, Department of Surgery, Emory University School of Medicine, Atlanta, GA.
Yang H; Department of Surgery, University of Pittsburgh Medical Center Pinnacle, Harrisburg, PA.
Allamassey L; Bristol Myers Squibb, Braine I'Alleud, Belgium.
Polinsky M; Bristol Myers Squibb, Princeton, NJ.
Formica RN; Section of Nephrology, Yale School of Medicine, New Haven, CT.

Transplant Direct ; 9(2): e1419, 2023 Feb.

Article em En | MEDLINE | ID: mdl-36700062

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Revista: Transplant Direct Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Canadá

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google